The ␣6 subunit of the nicotinic acetylcholine receptor (nAChR) is expressed at very high levels in dopaminergic (DA) neurons. However, because of the lack of pharmacological tools selective for ␣6-containing nAChRs, the role of this subunit in the etiology of nicotine addiction remains unknown. To provide new tools to investigate this issue, we generated an ␣6 nAChR knock-out mouse. Homozygous null mutants (␣6Ϫ/Ϫ) did not exhibit any gross neurological or behavioral deficits. A careful anatomic and molecular examination of ␣6Ϫ/Ϫ mouse brains demonstrated the absence of developmental alterations in these animals, especially in the visual and dopaminergic pathways, where the ␣6 subunit is normally expressed at the highest levels. On the other hand, receptor autoradiography revealed a decrease in [ Because ␣CtxMII, a toxin formerly thought to be specific for ␣3␤2-containing nAChRs, is known to partially inhibit nicotineinduced dopamine release, these results support the conclusion that ␣6 rather than ␣3 is the partner of ␤2 in the nicotinic modulation of DA neurons. They further show that ␣6Ϫ/Ϫ mice might be useful tools to understand the mechanisms of nicotine addiction, although some developmental compensation might occur in these mice.
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Key words: nicotinic acetylcholine receptor; knock-out; ␣6 subunit; ␣-conotoxinMII; dopaminergic system; visual system As many drugs of addiction, nicotine is thought to exert its addictive properties through stimulation of dopamine release in the nucleus accumbens (Nac) (Pontieri et al., 1996; Di Chiara, 2000) . This effect of nicotine has been attributed to a direct activation of nAChRs located on dopaminergic (DA) neurons of the ventral tegmental area (VTA). Indeed, nicotine is known to increase the firing rate of these neurons, both in vitro (Pidoplichko et al., 1997) and in vivo (Grenhoff et al., 1986) . Moreover, nicotinic antagonists infused into the VTA prevent nicotine elicited dopamine release in the Nac and disrupt systemic nicotine self-administration in rats (Corrigall et al., 1994; Nisell et al., 1994) . Therefore, nAChRs expressed by DA neurons represent valuable targets for the design of new pharmacological agents for the treatment of nicotine abuse, and much research has been devoted to the identification of their subunit composition.
Neuronal nAChRs are composed of five subunits belonging to a family of at least 12 genes exhibiting a discreet expression pattern (Sargent, 1993) . DA neurons express ␣3, ␣4, ␣5, ␣6, ␣7, ␤2, and ␤3 subunits (Le Novère et al., 1996; Charpantier et al., 1998; Klink et al., 2001 ). Furthermore, it was recently demonstrated that mice lacking the ␤2 subunit are no longer sensitive to nicotine-mediated dopamine release in the Nac and fail to selfadminister nicotine . The same study demonstrated that ␤2-containing nAChRs, present on the soma of DA neurons, mediate a nicotine-induced increase of their firing rate. Among the other subunits expressed in VTA, only ␣3, ␣4, and ␣6 are likely to associate with the ␤2 subunit to form a ligand binding site [␤3 and ␣5 are structural subunits, whereas ␣7 forms homomeric pentamers (Le ]. Although pharmacological evidence suggests ␣4 and ␣3 subunits as likely partners of the ␤2 subunit (Kulak et al., 1997; Kaiser et al., 1998; Sharples et al., 2000) , the existence of functional ␣6-containing nAChRs on DA neurons should not be overlooked. Indeed, the ␣6 subunit is specifically and highly expressed in catecholaminergic neurons and retina (Le Novère et al., 1996; Vailati et al., 1999) . In addition, ␣6 was recently implicated in the stimulating effect of nicotine on habituated locomotion , an effect known to be blocked by lesions of midbrain DA neurons (Boye et al., 2001) . However, the absence of pharmacological information about ␣6-containing nAChRs has been a deterrent to determining the exact contribution of these receptors to the nicotinic modulation of DA neurons.
To investigate this issue, we generated a strain of mice lacking the ␣6 nAChR subunit gene. We describe the generation of these animals and their anatomical characterization. We first focus on the detection of possible developmental abnormalities in dopaminergic and visual pathways, because such alterations might secondarily affect behavior and have already been detected in ␤2 nAChR knock-out mice (Rossi et al., 2001) . Then, we perform ligand binding experiments to investigate the pharmacology and distribution of native ␣6-containing nAChRs and evaluate the representation of these receptors in the dopaminergic system.
MATERIALS AND METHODS
All animals were used in accordance with the C entre National de la Recherche Scientifique guidelines for care and use of laboratory animals.
Construction of the targeting vector
We used a PCR-based strategy (Israel, 1993) to screen a mouse genomic DNA library prepared from the 129Sv/d3 embryonic stem (ES) cells strain (Stratagene, La Jolla, CA), using primers derived from the ␣6 cDNA rat sequence. An 18 kb clone was isolated, and homologous flanking regions were cloned in K S bluescript (Stratagene), on either side of a Neomycin resistance gene. Ultimately, a diphtheria toxin expression cassette was introduced outside of the recombination arms. The construct was designed to generate a nonf unctioning allele by deleting a 4 kb EcoRI-HindIII fragment including exons 1 and 2 of the ␣6 gene. The 5Ј flanking arm was a 5 kb EcoRI-EcoRI fragment, and the 3Ј flanking arm was a 2.4 kb HindIII-SalI fragment (Fig. 1) .
Generating the chimeras
The targeting vector was linearized by ScaI and electroporated in ES cells derived from the 129Sv/ Pas mouse strain (Kress et al., 1998) . After 8 d of geneticin selection (Invitrogen, Gaithersburg, MD), 200 resistant clones were screened by genomic Southern blot for homologous recombination. Three recombinant ES cells clones were obtained, one of which was used to generate mouse chimeras by aggregation (K hillan and Bao, 1997) with morulas obtained from CD1 mice (Charles River, Wilmington, M A). One single germline transmitter was obtained and bred with CD1 mice.
Maintaining the colony
One F1 heterozygous male and one F1 heterozygous female were then mated to establish a set of F2 breeder animals (5 males and 10 females) of each genotype (mutant or wild-type). All the animals used in this study were derived either from the F2 or the F3 generation. Genetic diversity was maintained by randomly interchanging breeders.
Genomic Southern blot
Genomic Southern blot was performed according to standard methods (Sambrook et al., 1989) . A PstI digest of mouse tail-derived genomic DNA probed with a SalI-PstI fragment ( Fig. 1 ) was used to check the recombination at the 3Ј end (normal allele fragment is 8.1 kb and recombinant is 4.0 kb). Another probe (EcoRI-EcoRV fragment of the ␣6 promoter), internal to the 5Ј recombination arm, was used to check for correct recombination on the 5Ј end, using an XbaI digest of genomic DNA. (Normal allele fragment is 9.9 kb and recombinant is 12.2 kb). This also excluded the eventuality of an additional random integration (data not shown).
In situ hybridization
Animals were killed by cervical dislocation, and the brain was quickly dissected out and frozen in dry ice powder. The tissues were stored at Ϫ80°C until cut on a cryostat (Leica, Deerfield, IL) (14-m-thick sections). In situ hybridization was performed according to Z oli et al. (1995) , using synthesized oligonucleotides (Eurogentec, Brussels, Belgium) according to rat or mouse sequence, when available (Table 1) . The slides were then exposed for 15 d to Hyperfilm-3H (Amersham Biosciences, Arlington Heights, IL) together with microscale radioactive standards (Amersham Biosciences) to correct for nonlinearity of the film response. The semiquantitative analysis was performed on autoradiography films. On each section, an averaged optical density of the background level (obtained by cold competition with unlabeled oligonucleotide) was subtracted from that of the sampled area to obtain specific optical density value.
For nAChR subunits (␣3, ␣4, ␣5, ␣6, ␣7, ␤2, ␤4), the experiment was performed using 3-6 animals of each genotype. Sections were taken at 17 coronal levels (bregma levels: 3.0, 1.5, 0.9, 0.1, Ϫ0.6, Ϫ1.0, Ϫ1.8, Ϫ2.2, Ϫ2.7, Ϫ2.9, Ϫ3.1, Ϫ3.5, Ϫ3.8, Ϫ4.0, Ϫ4.8, Ϫ5.4, and Ϫ7.5 mm according to Franklin and Paxinos (1997) .
For dopamine receptors (D1, D2), tyrosine hydroxylase (TH), and 
Spontaneous locomotor activity
The open-field apparatus consists of a transparent 31-cm-high ϫ 49-cmlong ϫ 25.4-cm-wide Plexiglas cage. Movements were detected by a set of 9 ϫ 19 infrared photobeam detectors, 1.5 cm above the floor of the apparatus. Tests were performed in a quiet room with ambient fluorescent lighting. For this experiment we used 15 male ␣6Ϫ/Ϫ mice and 15 wild-type (Wt) littermates controls derived from F2 heterozygous mating. Mice naive to the apparatus were placed in the cage at time point t ϭ 0, and their movements were recorded for a 2 hr period, with time points taken at intervals of 5 min.
Intraocular injections
Mice were anesthetized with a solution of 1.5% ketamine and 0.05% xylazine in PBS (150 l /30 gm body weight). Intraocular injections were performed using a glass needle inserted just behind the corneoscleral margin of the eye. One microliter of a 10 g/l solution of cholera toxin subunit B, Alexa Fluor 488 conjugate (Molecular Probes, Eugene, OR) was injected into the vitreous chamber of one eye and Alexa Fluor 594 into the other. After 24 hr, mice were anesthetized and perf used with 0.9% saline, followed by 4% paraformaldehyde in PBS. Cryoprotected brains were cut on a freezing microtome into 40 m coronal sections. Sections were mounted on gelatin-coated slides, air-dried, coverslipped, and then examined under an epifluorescent microscope. Whiteaker et al. (2000) . For each ligand, 17 coronal levels (see in situ hybridization procedures), and one or two sections per level were examined, from three to five animals of each genotype. Nonspecific binding was determined by using a 1000ϫ excess of unlabeled ligand.
Receptor autoradiography
C ytisine displacement of [ 3 H]epibatidine binding was performed by adding 50 nM of cold cytisine to the incubation mix, according to Marks et al. (1998) .
E xcept for [ 125 I]-␣C txM II, which was a generous gift from Dr. J. Michael McIntosh (Departments of Biology and Psychiatry, University of Utah, Salt Lake C ity, UT), all radiolabeled ligands were purchased from Amersham Biosciences. Unlabeled cytisine, nicotine, epibatidine, and ␣-bungarotoxin were purchased from Sigma (St. L ouis, MO); ␣C txM II was obtained from Eurogentec.
Dopamine receptor ligands. Levels of D1 and D2 dopamine receptors were determined by equilibrium binding of [ 3 H]SCH23390 (N EN, Boston, M A) and [
3 H]raclopride (N EN), respectively. Sections were preincubated for 30 min at room temperature in 50 mM Tris 7.4, 120 mM NaC l, 5 mM KC l, 2 mM CaCl 2 , 2 mM MgC l 2 (SCH23390), or 50 mM Tris 7.4, 120 mM NaC l, and 5 mM KC l (raclopride). Slides were then incubated for 1 hr at room temperature in preincubation buffer plus 1.5 nM (SCH23390) or 3 nM (raclopride) of tritiated ligand. Nonspecific binding was determined in the presence of an excess (100ϫ) of cold ligand (Research Biochemicals, Natick, M A). After incubation, the sections were washed three times for 5 min each in ice-cold 50 mM Tris and briefly rinsed in ice-cold water. Slides were exposed for 20 d (D1) or 40 d (D2) to Kodak (Eastman Kodak, Rochester, N Y) BioMax MS films (Amersham Biosciences). Eight animals of each genotype were used for quantification. Measures were made on three adjacent sections at mesencephalic and striatal levels (bregma Ϫ3.4 and 0.9 mm, respectively).
Histological analysis
Immunoc ytochemistr y. Mice were anesthetized with 4% chloral hydrate (12 l /gm) and transcardially perf used with 20 ml of 0.9% NaC l (37°C) followed by 100 ml of a 4% paraformaldehyde -PBS solution. Brains were dissected out and post-fixed overnight in the same fixative, rinsed in 12% sucrose -PBS at 4°C over 2 d, and frozen on dry ice powder. The brains were cut from bregma level 1.0 -0.7 mm and from bregma level Ϫ3.1 to Ϫ3.5 mm on a cryostat (20-m-thick sections). Sections were then processed according to standard immunoperoxidase protocols, using the avidin -biotin complex technique (Pedrazzi et al., 1998) . Antibodies against rat tyrosine hydroxylase (TH) (C albiochem, La Jolla, CA), and dopamine transporter (DAT) (M AB369; Chemicon, Temecula, CA) were used at a 1:2000 dilution for TH and 1:1000 for DAT. Briefly, slides were incubated overnight at 4°C, in the presence of the primary antibody diluted in PBS supplemented with 0.2% Triton X-100 and 1% normal goat serum (NGS). After washing with PBS containing 0.1% NGS, sections were incubated for 1 hr at room temperature, with a biotinylated anti-rabbit (TH) or anti-rat (DAT) secondary antibody (Vector Laboratories, Burlingame, CA) diluted 1:200 in PBS/1% NGS. Sections were washed in PBS and incubated with an avidin biotinylated peroxidase complex (ABC) according to manufacturer's instructions (Vector Laboratories). After peroxidase detection using diaminobenzidine, sections were washed, dehydrated, and coverslipped.
Nissl staining. Rehydrated, fixed (4% PFA) brain sections were incubated with toluidine blue (0.1%), washed, dehydrated, and coverslipped.
Anal ysis. The semiquantitative evaluation of the intensity of TH and DAT immunostainings as well as automatic cell profile count of Nisslstained preparations was performed by means of an automatic image analyzer (K S300; Z eiss Kontron, Munich, Germany) according to previously published methods (Z oli et al., 1992) . Microdensitometric analysis of immunostaining was performed with a CCD camera connected to a microscope using a 2.5ϫ objective. In mesencephalon, a thresholding The melting temperature (Tm) is calculated for the most stringent wash condition (0.01 M NaCl, 0% formamide) as described by Le Novère et al. (1996) . The indicated position is in reference to the A of the ATG. When the oligonucleotide was designed according to the rat cDNA sequence, and when corresponding mouse cDNA sequence was available, we indicated the number and position (lowercase characters) of the mismatches. ("?" means that the mouse cDNA sequence was not available).
procedure was used to determine the integrated optical density value. TH-immunoreactive cell counting in substantia nigra pars compacta (SNc) was performed manually on coded slides under a 20ϫ objective using a calibrated eyepiece grid, at Ϫ3.5 mm bregma level. For each staining, the analysis was performed on two sections per animal. The average value per animal was used for statistical purposes. For Nissl-stained preparations, automatic cell profile count was performed according to Z oli et al. (1993) with a CCD camera connected to a microscope using a 20ϫ objective (rectangular sampled field, 310 ϫ 235 m). Briefly, stained profiles were separated from the background by means of a dynamic thresholding procedure. Then, a spatial threshold was placed to separate glial (diameter Ͻ 7.5 m) from neuronal (diameter Ն 7.5 m) profiles, and the number of neuronal profiles per sampled field was measured.
Membrane binding. Membranes from striatum (dorsal and ventral) and superior colliculus (SC) were prepared according to Marks et al. (1998) . Incubations were performed in 6 ml glass tubes, using 50 (Superior colliculus) or 200 g (striatum) of membrane protein per tube. Membranes were diluted in 500 l of binding buffer (NaC l 144 mM; KC l 1.5 mM; CaCl 2 2 mM; MgSO 4 1 mM; H EPES 20 mM, pH 7.5), containing [ 3 H]epibatidine (500 pM) and the appropriate concentration of unlabeled ligand (300 pM to 10 M for ␣C txM II, and 30 pM to 3 M for cytisine). For ␣C txM II displacement, binding buffer was supplemented with BSA (0.1% w/ v), 5 mM EDTA, 2 mM EGTA, and 10 g /ml each of aprotinin, pepstatin A, and leupeptin (Sigma), to protect the ligand from endogenous proteases. After 2 hr at room temperature, incubations were terminated by filtration on polyethilenimine-soaked (0.3%, Sigma) glass fiber filters (type GF/C; Whatman) and washing with 10 ml of ice-cold binding buffer. Nonspecific binding was determined by adding an excess (1000ϫ) of unlabeled epibatidine to the incubation mix. All measures were made in triplicate. The epibatidine concentration and the volume used for the incubation ensured minimal ligand depletion (Ͻ5%). Results were first fitted to the Hill equation
n ) ] to determine the likeliness of a monophasic inhibition (B is the number of binding sites at inhibitor concentration, I, B o is the binding in the absence of inhibitor, and n is the Hill coefficient). Depending on n value, results were fitted using one of the following equations for one or two binding sites: B ϭ B o /(1ϩ (I/IC 50 )) or B ϭ I B 1 /(1 ϩ (I/IC 50 -1 )) ϩ B 2 /(1ϩ (I/IC 50 -2 )), respectively. IC 50 and B o values are expressed as the means Ϯ SEM of six independent determinations. The corresponding K i value was determined assuming competitive inhibition: Marks et al. (1998) .
Statistical anal ysis. Statistical analysis was done with StatView software (SAS Institute). Data are given as means Ϯ SEM; means were compared using a Student's t test.
RESULTS

Generation of ␣6 knock-out mice
Knock-out mice for the ␣6 subunit of the nAChRs were generated by replacing the first two exons of the gene with a Neomycin resistance (Neo r ) cassette (Fig. 1a) . These exons encode the ATG initiator codon, the signal peptide, and part of the N-terminal extracellular domain of the mature subunit. Southern blot analysis using a flanking genomic probe confirmed that the expected homologous-recombination had occurred (Fig. 1b) . In situ hybridization using an oligonucleotide probe located in the sixth exon (downstream to the deletion) detected ␣6 mRNA in retinal ganglion cells (RGCs), locus coeruleus (LC), substantia nigra (SN) and VTA neurons of Wt animals, in agreement with previous observations in rat or chicken (Le Novère et al., 1996; Vailati et al., 1999) . In heterozygous mice, the intensity of the signal decreased and completely disappeared in ␣6Ϫ/Ϫ mice, demonstrating that the deletion of exon 1 and 2, and the insertion of the Neo r cassette, is sufficient to prevent transcription (Fig. 1c) . We then compared the levels of expression of ␣3, ␣4, ␣5, ␣7, ␤2, and ␤4 nAChR subunit mRNA in Wt and ␣6Ϫ/Ϫ animals. Quantitative analysis of film autoradiography revealed no alteration in the relative abundance of the mRNA of these subunits to compensate for the loss of the ␣6 subunit (Fig. 2). [Note that in agreement with Ross et al. (2000) , ␣3 mRNA was not detected in SN-VTA neurons.] ␣6 knock-out mice are viable and do not exhibit major defects Homozygous null mutant mice are viable, present in the expected Mendelian proportion in litters, grow to normal size, and do not exhibit major physical or neurological defects. Home cage behavior of mutant mice appeared normal, and spontaneous locomotor activity in an open-field observed over a 2 hr period did not reveal significant differences between Wt and ␣6Ϫ/Ϫ animals at any time point, either during the nonhabituated (first hour) or habituated period (second hour) of the experiment (data not shown). Furthermore, histological examination of toluidine blue-stained sections of ␣6Ϫ/Ϫ mice did not reveal alterations in the size, shape, or location of the major brain nuclei (data not shown).
Absence of developmental adaptations in the dopaminergic and visual pathways of ␣6؊/؊ animals
One major drawback of knock-out animal studies is the possible existence of developmental abnormalities in mutant mice that Figure 2 . Semiquantitative analysis of ␣3, ␣4, ␣5, ␣7, ␤2, and ␤4 nAChR subunit mRNAs in Wt and Mt mice using in situ hybridization. For each subunit, optical density value of the signal was measured and corrected for background and film linearity. This value was then normalized to 100 in the region where the signal was maximal. Results are expressed as means Ϯ SEM of at least three animals. Statistical analysis was performed using an unpaired Student's t test (p Ͻ 0.05). Regions quantified were medial habenula (MHb), interpeduncular nucleus (IPN ), thalamus (Th), cortex (Cx), VTA, and hippocampus (Hp). Note the absence of significant differences in the relative abundance of the mRNA of these subunits, in any brain region.
might interfere with the interpretation of the results obtained from these studies. For instance, in mice lacking the ␤2 nAChR subunit, impairment of visual acuity derives from abnormal segregation of retinogeniculate projections during development (Rossi et al., 2001) . To examine whether such alterations exist in ␣6Ϫ/Ϫ animals, we performed a detailed examination of the anatomical regions where ␣6 is known to be expressed.
In the visual system, histological staining of the retina showed that the cell layering and the RGC number is normal in ␣6Ϫ/Ϫ mice compared with their Wt controls (data not shown). Moreover, we studied the distribution pattern of RGC projections in their thalamic target, the dorsolateral geniculate nucleus (dLGN), in young (postnatal day 15) and adult animals. In Wt mice, retinal projections from the two eyes terminate into separated areas of the dLGN: an outer shell, that receives afferents exclusively from the contralateral eye and an inner core that is innervated by the ipsilateral eye. In ␣6Ϫ/Ϫ mice the pattern of retinogeniculate labeling was not different from the one observed in Wt at the same age (data not shown).
The anatomy of the mesostriatal dopaminergic system was studied at both mesencephalic and striatal levels.
At the striatal level, the semiquantitative analysis of TH and DAT immunoreactivity failed to detect any alteration in DA nerve terminals of ␣6Ϫ/Ϫ mice in the anatomical regions examined [caudate-putamen (Cpu), Nac, and olfactory tubercle (Tu)]. Intrinsic striatal neurons also appeared normal in terms of number and morphology, as assessed by Nissl staining. Using in situ hybridization and receptor autoradiography, we examined the expression profile of several markers in these neurons: dopamine receptors, D1 and D2, and neuropeptide precursors, PPT and PPE. In Wt mice, D1 and D2 mRNA levels were found to be homogeneously expressed in Cpu, and Tu, and to a lesser extent in the Nac. The study of [ 3 H]raclopride (D2) and [ 3 H]SCH23390 (D1) binding revealed a similar pattern of expression at the protein level. PPT mRNA, coding for the precursor peptide of substance P, was strongly expressed in Tu and Nac shell and to a lesser extent in Cpu and Nac core. Finally, PPE mRNA, coding for the precursor peptide of methionine-enkephalin, was homogeneously expressed in Cpu, Nac, and Tu. In ␣6Ϫ/Ϫ mice, the pattern and level of expression of these markers were not altered (Table 2) .
At the mesencephalic level, the morphology and number of DA neurons did not differ in Wt and ␣6Ϫ/Ϫ mice when visualized by TH or DAT immunoreactivity. We then examined the expression of TH, dopamine receptors D1, D2, and neuropeptide CCK at the mRNA level. In Wt mice, TH and D2 mRNA was detected in VTA and substantia nigra pars compacta (SNc) only, whereas CCK was also expressed in cortex and hippocampus. D1 mRNA was not detected at the mesencephalic level. Ligand binding studies further revealed low levels of [ 3 H]raclopride (D2) binding sites in VTA and SNc, whereas high levels of [ 3 H]SCH23390 (D1) binding sites could be seen in SN reticulata. Statistical analysis did not reveal any significant difference in the expression of these markers, between Wt and ␣6Ϫ/Ϫ animals ( Table 2 ). (Fig. 3a-c) . Surprisingly, no other differences were detected, especially in the retina, SN-VTA, and striatum, brain regions containing cell bodies or terminals of neurons that express ␣6. Small decreases, however, might have been masked because of the relative scarcity of ␣6-containing nAChRs with respect to other major nAChR populations (e.g., ␣4␤2 containing nAChRs) that also bind these ligands. As shown in a previous paper (Marks et al., 1998) , a subpopulation of [ 3 H]epibatidine binding sites, enriched in the mesostriatal and visual pathways, has a relatively low affinity for cytisine ("cytisine-resistant" sites). We therefore, compared the distribution of [ 3 H]epibatidine binding sites after displacement by low cytisine concentration (50 nM), in Wt and ␣6Ϫ/Ϫ mice. In these conditions, autoradiography quantification revealed a significant decrease of the cytisineresistant fraction of [ 3 H]epibatidine binding sites in most regions of the visual and dopaminergic systems of mutant animals compared with Wt mice (Figs. 3d, 4) .
Distribution of high-affinity binding sites for nicotinic ligands in the brain of ␣6؊/؊ mice
Finally, we examined the distribution of [ 125 I]␣CtxMII binding sites. In Wt mice, our results were in agreement with those of Whiteaker et al. (2000) . Briefly, the highest density of [ 125 I]␣CtxMII binding sites was found in the SC (zonal and superficial gray layer), optic tract (opt), geniculate nucleus, and olivary pretectal nucleus (OPN). Lower levels were found in the basal ganglia (including Cpu, Tu, and Nac), SN-VTA, interpeduncular nucleus (IPN), medial habenula (MHb), lateral habenula, fasciculus retroflexus (fr), and retina. It should be noted that these regions correspond to ␣6-expressing neurons (Le Novère et al., 1996) and to their terminal fields. In ␣6Ϫ/Ϫ mice, no signal was detected above background level, indicating a complete disappearance of high-affinity ␣CtxMII binding sites (Fig. 5) .
Disappearance of the ␣CtxMII-sensitive and the cytisine-resistant fractions of [ 3 H]epibatidine binding sites in the striatum of ␣6؊/؊ mice
Receptor autoradiography experiments showed a high selectivity of ␣CtxMII for ␣6-containing nAChRs (see above). Still, previous experiments showed that this ligand is a potent inhibitor of ␣3␤2-containing nAChRs (Cartier et al., 1996) . We, therefore, (Table 3) . On the contrary, in ␣6Ϫ/Ϫ animals, ␣C txM II had no effect on epibatidine binding at any concentration (up to 10 M). Strikingly, the total number of ␣C txM IIresistant epibatidine binding sites was significantly upregulated in ␣6Ϫ/Ϫ mice ( p Ͻ 0.01) (Fig. 6) . We also performed the same experiment on SC membrane preparations and found residual ␣C txM II sensitivity in ␣6Ϫ/Ϫ mice, representing 16% of the ␣C txM II-sensitive [ 3 H]epibatidine binding population in Wt animals (Table 3) . However, the low amount of these sites and problems with material availability prevented us from providing an accurate inhibition curve that could have demonstrated the low-affinity nature of these sites.
Because ␣CtxMII-sensitive and cytisine-resistant [ 3 H]epibatidine binding sites have been suggested to represent the same receptor population , we investigated the displacement of epibatidine binding by unlabeled cytisine. The resulting inhibition curves are shown in Figure 7 . In Wt animals, the Hill coefficient was significantly Ͻ1 (n ϭ 0.76 Ϯ 0.03), suggesting that the inhibition of epibatidine binding by cytisine was not monophasic. Results were thus fitted using a two sites model that revealed the existence of cytisine-sensitive and cytisineresistant epibatidine binding sites (Table 4) , in agreement with the results of Marks et al. (1998) . On the contrary, in ␣6Ϫ/Ϫ animals, the inhibition curve appeared monophasic (Hill coefficient, 0.94 Ϯ 0.05), and we could fit the data to a one site model to determine K i value (Table 4) . Using a two sites model to fit the data gave similar results because the calculated cytisine-resistant population represented Ͻ0.3% of total binding in ␣6Ϫ/Ϫ animals. Moreover, the measured K i value for cytisine inhibition of epibatidine binding in ␣6Ϫ/Ϫ animals was comparable with the K i value of the cytisine-sensitive fraction in Wt mice (0.32 Ϯ 0.03 nM compared with 0.23 Ϯ 0.03 nM, respectively).
DISCUSSION
We describe the generation and phenotypic characterization of an ␣6 nAChR subunit knock-out mouse, focusing on the anatomy of neuronal structures where ␣6 is normally expressed and on the pharmacological properties of native ␣6-containing nAChRs. Deletion of the first two exons of the ␣6 gene was sufficient to impair its transcription, as evidenced by the absence of residual ␣6 mRNA in homozygous null mutant mice. These animals exhibit normal general appearance, survival, growth, anatomy, and locomotor behavior. 
The anatomy of the dopaminergic and visual pathways is preserved in ␣6؊/؊ animals
Because ␣6 mRNA is abundantly expressed in catecholaminergic neurons and RGCs, we examined whether developmental alterations occurred in the dopaminergic and visual systems of ␣6Ϫ/Ϫ animals as a consequence of the loss of the ␣6 subunit. In the dopaminergic system, no anatomical alterations could be detected in either midbrain DA neurons at the somatic and terminal levels, or in intrinsic striatal neurons. Moreover, the expression of various molecular markers, including the dopamine biosynthetic enzyme and transporter (TH and DAT, respectively), dopamine receptors (D1, D2) and neuropeptides (CCK, PPT, PPE) were normal in ␣6Ϫ/Ϫ mice, although the expression of some of these markers has been reported to be modulated by nicotine or endogenous acetylcholine (Wiener et al., 1989; Smith et al., 1991; Houdi et al., 1998; Drew et al., 2000) . In the visual system, retinal cell layering as well as the organization of retinothalamic projections were preserved in ␣6Ϫ/Ϫ animals. Relying on our results, we conclude that ␣6 is not necessary for normal development of visual and mesostriatal dopaminergic pathways. Therefore, these mutant animals are likely to be suitable models for studying the function of ␣6 in adults.
Moreover, our results contribute to the identification of the subunit composition of nAChRs responsible for the segregation of retinothalamic projections. In the visual system of mammals, the projections of the RGC from each eye are initially intermixed in their thalamic target, the dLGN, and subsequently segregate into eye-specific layers. This phenomenon is dependent on spontaneous retinal activity, termed retinal waves, driven by the activation of nicotinic receptors located on RGC (Feller et al., 1996; Penn et al., 1998) . It was recently demonstrated that mice lacking the ␤2 but not the ␣4 nAChR subunit, display abnormal segregation of retinogeniculate projections (Rossi et al., 2001) . In this context, our finding that adult ␣6Ϫ/Ϫ mice exhibit normal segregation, suggests that nAChRs involved in the segregation process do not contain ␣6, although the substitution of ␣6 by another ␣ subunit cannot be ruled out (see below). These results further support the hypothesis of Bansal et al. (2000) , who proposed ␣3 as the likely partner of ␤2 in the genesis of normal retinal waves.
The ␣6 nAChR subunit is a critical component of native ␣CtxMII binding sites Null mutant mice exhibit a complete disappearance of highaffinity [
125 I]␣CtxMII binding sites. Therefore, all these sites appear to correspond to ␣6-containing nAChRs. Three distinct anatomical systems contain detectable levels of [ 125 I]␣CtxMII binding. High levels were shown in the visual system, including retina, RGC fibers (opt), and their terminal fields (geniculate nucleus, SC, OPN). Lower binding density was found in two other systems: the mesostriatal dopaminergic system, which includes SN-VTA neurons and their projection structures (Tu, Nac, Cpu, lateral habenula), and the habenulo-interpeduncular system (MHb, fr, and IPN). On the basis of the distribution of ␣6 mRNA-expressing neurons, we infer that ␣6-containing nAChRs in the SN-VTA, MHb, and retina are somatodendritic receptors. In other regions, these receptors are likely to be transported to a presynaptic or preterminal localization, as confirmed by the presence of high levels of [
125 I]␣CtxMII binding in axon systems (optic nerve and tract, fr). Our results expand those of Goldner et al. (1997) , who detected ␣6 immunoreactivity only in the SN-VTA. However, it should be noted that ␣CtxMII-insensitive ␣6-containing nAChRs might also exist, as suggested by the fact that ␣6 mRNA was detected in areas, such as the LC (Le Novère et al., 1996; Lena et al., 1999) , where no [
125 I]␣CtxMII binding was detected.
Although ␣CtxMII was thought to be a specific inhibitor of ␣3␤2-containing nAChRs (Cartier et al., 1996) , the sensitivity of ␣6-containing nAChRs to this toxin is not surprising. Indeed, ␣3 and ␣6 are highly homologous subunits with 67.3% residue identity in their mature N-terminal domains, and critical residues for ␣CtxMII selectivity are conserved in ␣6 (Harvey et al., 1997) . Moreover, it was recently demonstrated that native ␣6␤4-containing nAChRs, purified from chick retina, are blocked by this toxin (Vailati et al., 1999) . Finally, chimeric subunits containing the extracellular domain of the human ␣6 subunit fused to the rest of ␣3 or ␣4 subunits can form functional nAChRs, sensitive to ␣CtxMII, when expressed with ␤2 or ␤4 in Xenopus oocytes (Kuryatov et al., 2000) . More intriguing, however, is the fact that ␣CtxMII binding sites completely disappear in ␣6Ϫ/Ϫ mice, although ␣3 is still expressed. It is possible that ␣3␤2-containing nAChRs are not detected because of the scarcity of these sites. In the SN-VTA, ␣3 mRNA is barely detectable using in situ hybridization (Le Novère et al., 1996; Ross et al., 2000; present study) , whereas in regions where ␣3 mRNA is abundant (e.g., in MHb), ␣CtxMII-insensitive ␣3␤4-containing nAChRs are likely to form (Quick et al., 1999) . Another explanation would be that ␣3␤2-containing nAChRs form low-affinity ␣CtxMII binding sites, which could not be detected using receptor autoradiography. In the SC, this hypothesis is supported by our results on ␣CtxMII displacement of [ 3 H]epibatidine binding on membrane preparations and the findings of Dougherty et al. (2000) , which suggest that some non-␣6-containing nAChRs with low affinity for ␣CtxMII are present in this region. In the striatum however, such sites are unlikely to exist because in Wt mice, in agreement with Whiteaker et al., (2000) , we report a monophasic of inhibition of [ 3 H]epibatidine binding by ␣CtxMII, and because, in ␣6Ϫ/Ϫ animals, residual [ 3 H]epibatidine binding is insensitive to ␣CtxMII displacement (up to 10 M).
Overall, our results prompt a new interpretation of previous works describing the pharmacological actions of ␣CtxMII on DA neurons. This toxin partially inhibits nicotine-induced dopamine release in striatal synaptosomes (Kulak et al., 1997; Kaiser et al., 1998) . Moreover, patch-clamp recordings revealed ␣CtxMII-sensitive nAChR-mediated currents in midbrain DA neurons (Klink et al., 2001 ). Relying on the supposed selectivity of ␣CtxMII, it was proposed that ␣3␤2-containing nAChRs mediate these nicotinic effects. We demonstrate here that this is unlikely to be the case. First, the selectivity of ␣CtxMII for ␣3␤2-containing nAChRs is questionable because native ␣6-containing nAChRs exhibit nanomolar affinity for this toxin. Moreover the absence of residual ␣CtxMII binding sites in the striatum of ␣6Ϫ/Ϫ animals, and the low abundance of ␣3 mRNA in the SN/VTA suggest that ␣3␤2-containing nAChRs are very scarce in the dopaminergic system. Consequently, the role of the ␣6 subunit in the nicotinic modulation of DA neurons and its importance for nicotine addiction should be reevaluated taking ␣6␤2-containing nAChR rather than ␣3␤2-containing nAChR as the likely candidate for these effects.
Evidence for the existence compensatory mechanisms in ␣6؊/؊ animals Pharmacological characterization of native ␣6-containing nAChRs was completed using various nicotinic agonists. Cytisine displacement of [ 3 H]epibatidine binding on striatal membranes strongly suggested the identity of cytisine-resistant and ␣CtxMII-sensitive epibatidine binding sites in the striatum, because both types of sites represent the same proportion of total epibatidine binding (ϳ20%), and disappear in ␣6Ϫ/Ϫ animals. Furthermore, autoradiography experiments demonstrated the existence of ␣6-containing binding sites with high affinity for nicotine, epibatidine, and cytisine, exclusively in SC and dLGN of Wt animals. In the mesostriatal dopaminergic system, however, no significant difference could be detected between Wt and ␣6Ϫ/Ϫ animals. This is unlikely to be simply attributable to a lack of sensitivity of our assay because displacement of [ 3 H]epibatidine binding by ␣CtxMII on striatal membranes revealed an increase of ␣CtxMII resistant sites in ␣6Ϫ/Ϫ animals compared with Wt mice. This observation suggests the existence of a developmental compensation in the striatum of ␣6Ϫ/Ϫ mice, where ␣6-containing nAChRs are replaced by new nicotinic receptors with a different pharmacology. To our knowledge this is the first demonstration of the existence of compensatory mechanisms in nAChRs subunit knock-out mice, although a similar phenomenon has been suggested in ␣4 knock-out mice (Klink et al., 2001) . The exact molecular mechanism of this compensation is unknown, although simple transcriptional upregulation seems unlikely according to our in situ hybridization results. Klink et al. (2001) suggested the existence of ␣4␣6␣5(␤2) 2 nAChRs in DA neurons. In the absence of ␣6, one may plausibly support the idea that this receptor assembles by recruiting a second ␣4 subunit. This would lead to the formation of a new cytisine-sensitive, ␣CtxMII-resistant, epibatidine binding site, without modifying the total amount of binding. Additional experiments however, are required to test this possibility and to evaluate the functional relevance of these new nAChRs in ␣6Ϫ/Ϫ animals. Finally, our results, in combination with those of Klink et al. (2001) and Kulak et al. (1997) , demonstrate the importance of the ␣6 nAChR subunit in the effects of nicotine on DA neurons. Provided that compensating mechanisms are taken into account, ␣6Ϫ/Ϫ mice might offer useful tools to further evaluate the contribution of the ␣6-containing nAChRs to nicotine addiction.
